Catalent
CTLT
#1590
Rank
ยฃ8.57 B
Marketcap
ยฃ47.22
Share price
1.15%
Change (1 day)
47.93%
Change (1 year)
Catalent is an American pharmaceutical contract research and development company.

Catalent (CTLT) - Total liabilities

Total liabilities on the balance sheet as of September 2024 : ยฃ4.87 Billion

According to Catalent's latest financial reports the company's total liabilities are ยฃ4.87 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Catalent - Total liabilities on balance sheet (from 2013 to 2024)

Total liabilities by year

Year Total liabilities Change
2023-06-30ยฃ4.88 B3.44%
2022-06-30ยฃ4.72 B35.21%
2021-06-30ยฃ3.49 B0.74%
2020-06-30ยฃ3.46 B13.05%
2019-06-30ยฃ3.06 B17.68%
2018-06-30ยฃ2.60 B24.24%
2017-06-30ยฃ2.09 B15.11%
2016-06-30ยฃ1.82 B14.54%
2015-06-30ยฃ1.59 B-21.68%
2014-06-30ยฃ2.03 B-7.98%
2013-06-30ยฃ2.20 B-0.71%
2012-06-30ยฃ2.22 B

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
ยฃ0.26 B-94.56%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ0.42 B-91.25%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ6.39 B 31.12%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
ยฃ0.25 B-94.79%๐Ÿ‡บ๐Ÿ‡ธ USA